Skip to main content
SpringerLink
Log in

Lymphedema following cancer therapy: overview and options

Clinical & Experimental Metastasis volume 35, pages 547–551 (2018)Cite this article

Abstract

This summit focusing on lymphedema following cancer therapy was held during the 7th International Symposium on Cancer Metastasis through the Lymphovascular System. It was unique for the inclusion of patients with lymphedema joining physicians, therapists, healthcare professionals, and researchers to highlight what is known and more importantly what is unknown about the current state of research and treatment in the United States. The session opened with an introduction to lymphedema and then explored the incidence of multiple cancer-related lymphedemas, imaging tools and techniques useful for the diagnosis of lymphatic system abnormalities, and the new findings concerning the genetics of cancer-related lymphedema. It closed with a review of advocacy for patients and healthcare professionals and both conservative and surgical treatment options, followed by a panel discussion and questions. The session provided important information and updates which will be of value for improving the rehabilitation and overall support of patients with cancer-related lymphedema.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. International Society of Lymphology (2016) The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology 49:170–184

    Google Scholar 

  2. Armer JM, Stewart BR, Shook RP (2009) 30-month post-breast cancer treatment lymphoedema. J Lymphoedema 4(1):14–18

    PubMed  PubMed Central  Google Scholar 

  3. Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM (2010) Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 116(22):5138–5149

    Article  PubMed  Google Scholar 

  4. Asellius G. De lactibus venis quarto vasorum mesaraicorum genere novo inuento, Mediolani, 1627, JB Biddellium. Reproduced in 1972 by Epistem Editrice, Milano

  5. Natale G, Bocci G, Ribatti D (2017) Scholars and scientists in the history of the lymphatic system. J Anat 231(3):417–429

    Article  PubMed  Google Scholar 

  6. Kinmonth JB (1972) The lymphatics: diseases, lymphography and surgery. Williams & Wilkins, Baltimore

    Google Scholar 

  7. Bernas M (2013) Imaging of the lymphatic system. In: Lymphedema management: the comprehensive guide for practitioners, 3rd edn. Thieme, New York

    Google Scholar 

  8. Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, Stazzone AM (2000) Advances in imaging of lymph flow disorders. Radiographics 20(6):1697–1719

    Article  CAS  PubMed  Google Scholar 

  9. Yamamoto T, Matsuda N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I (2011) The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg 128(4):314e–321e

    Article  CAS  PubMed  Google Scholar 

  10. Dori Y, Keller MS, Fogel MA, Rome JJ, Whitehead KK, Harris MA, Itkin M (2014) MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR 203:426–431

    Article  PubMed  Google Scholar 

  11. Rane S, Donahue PMC, Towse T, Ridner S, Chappell M, Jordi J, Gore J, Donahue MJ (2013) Clinical feasibility of noninvasive visualization of lymphatic flow with principles of spin labeling MR imaging: implications for lymphedema assessment. Radiology 269:893–902

    Article  PubMed  PubMed Central  Google Scholar 

  12. Brouillard P, Boon L, Vikkula M (2014) Genetics of lymphatic anomalies. J Clin Invest 124(3):898–904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Connell FC, Gordon K, Brice G, Keeley V, Jeffery S, Mortimer PS, Mansour S, Ostergaard P (2013) The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet 84:303–314

    Article  CAS  PubMed  Google Scholar 

  14. Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE (2008) HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol 6:65–68

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, Feingold E, Meriney SD, Brufsky AM, Ferrell RE (2012) Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res 18(8):1–9

    Article  CAS  Google Scholar 

  16. Newman B, Lose F, Kedda M-A, Francois M, Ferguson K, Janda M, Yates P, Spurdle AB, Hayes SC (2012) Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol 10:2–13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Fu MR, Conley YP, Axelrod D, Guth AA, Yu G, Fletcher J, Zagzag D (2016) Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction. Breast 29:231–240

    Article  PubMed  PubMed Central  Google Scholar 

  18. Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, Cooper BA, Elboim C, Neuhaus J, Schmidt BL, Smoot B, Aouizeratet BE (2013) Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS ONE 8(4):e60164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Leung G, Baggott C, West C, Elboim C, Paul SM, Cooper BA, Abrams G, Dhruva A, Schmidt BL, Kober K, Merriman JD, Leutwyler H, Neuhaus J, Langford D, Smoot BJ, Aouizerat BE, Miaskowski C (2014) Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery. Lymphat Res Biol 12(1):10–22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Smoot B, Kober KM, Paul SM, Levine JD, Abrams G, Mastick J, Topp K, Conley YP, Miaskowski CA (2017) Potassium channel candidate genes predict the development of secondary lymphedema following breast cancer surgery. Nurs Res 66(2):85–94

    Article  PubMed  PubMed Central  Google Scholar 

  21. Tam K, Shen L, Munneke JR, Ackerson LM, Partee PN, Somkin CP, Andre M, Kutner SE, Thiadens SRJ, Kwan ML (2012) Clinician awareness and knowledge of BCRL in a large, integrated healthcare delivery setting. Breast Cancer Res Treat 131(3):1029–1038

    Article  PubMed  Google Scholar 

  22. Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, Green JM, Stewart BR, Cormier JN, Armer JM (2012) A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM&R 4(8):580–601

    Article  Google Scholar 

  23. Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN (2013) Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep 5(2):134–144

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fu MR, Deng J, Armer JM (2014) Putting evidence into practice: cancer-related lymphedema. Clin J Oncol Nurs 18(Suppl):68–79

    Article  PubMed  Google Scholar 

  25. Boccardo F, Casabona F, De Cian F, Friedman D, Villa G, Bogliolo S, Ferrero S, Murelli F, Campisi C (2009) Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 16:703–708

    Article  PubMed  Google Scholar 

  26. Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM (2002) Physiotherapy after breast cancer surgery: results of a randomized controlled study to minimise lymphedema. Breast Cancer Res Treat 75:51–64

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. TCU and UNTHSC School of Medicine, Fort Worth, TX, USA

    Michael Bernas

  2. National Lymphedema Network (NLN), Napa, CA, USA

    Saskia R. J. Thiadens

  3. University of California San Francisco, San Francisco, CA, USA

    Betty Smoot

  4. University of Missouri Sinclair School of Nursing, Columbia, MO, USA

    Jane M. Armer

  5. Parkridge Medical Center Rehabilitation, Chattanooga, TN, USA

    Paula Stewart

  6. Siskin Hospital for Physical Rehabilitation, Chattanooga, TN, USA

    Paula Stewart

  7. Division of Plastic Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA

    Jay Granzow

  8. Harbor-UCLA Medical Center, Los Angeles, CA, USA

    Jay Granzow

Authors
  1. Michael Bernas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saskia R. J. Thiadens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Betty Smoot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jane M. Armer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paula Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jay Granzow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Bernas.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bernas, M., Thiadens, S.R.J., Smoot, B. et al. Lymphedema following cancer therapy: overview and options. Clin Exp Metastasis 35, 547–551 (2018). https://doi.org/10.1007/s10585-018-9899-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-018-9899-5

Keywords

search

Navigation